• 한국가금학회지
• /
• 제29권3호
• /
• pp.195-204
• /
• 2002

산란계에 대한 오전사료와 오후사료의 영양수준 및 급여방법이 산란능력과 경제성에 미치는 영향을 구명하기 위해 2개의 실험을 실시하였는데, 실험 1에서는 ISA Broun 갈색산란계 384수를 4처리 3반복, 반복당 32수씩을 공시하여 28~38주령에 2주간의 예비사양기간을 거쳐 본 시험 8주간 실시하였다. 대조구(C)는 관행적인 산란계 단일 배합사료를 급여하였고, 시험구들(T1, T2 및 T3)은 고에너지-고단백질-저 Ca의 오전사료와 저에너지-저단백질-고Ca의 오후사료를 별도로 급여하였다. 실험 2는 “ISA Brown” 갈색 산란계 384수를 3처리 4반복, 반복당 32수씩을 공시하여 48 ~ 58주령에 2주간의 예비사양기간을 거쳐 본 시험 8주간 실시하였다. 대조구(C)는 관행적인 산란계 단일 배합사료를 급여하였고, T1은 고에너지-고단백질-저Ca의 오전사료와 저에너지-저단백질-고Ca의 오후사료를 별도로 급여하였고, T2는 오전사료를 분말로 하고 오후사료를 펠렛으로 가공하여 50：50으로 혼합급여 하였다. 실험 1에서 헨데이 산란율과 평균난중 및 1일 1수당사료 섭취량은 대조구와 시험구들(T1-T3)간에 유의적인 차이가 없었다. 1일 1수당 ME, CP 섭취량 및 사료비는 대조구에 비해 시험구들(T1-T3)이 유의적으로 적었고(P<0.05), 시험구들간에는 오후사료의 ME및 CP 수준이 감소하고 Ca수준이 높아질수록 감소하는 경향이 있었다. 산란 개당 및 산란 kg당 사료, ME CP요구량과 사료비도 모두 대조구에 비해 시험구(T1-T3)들이 유의적으로 적었으며(P<0.05), 시험구들 간에는 오후사료의 Ca함량이 대조구에 비해 4배가 많은 73처리가 사료요구량에서 71과 72보다 많았고(P<0.05), 오후사료의 ME와 CP수준이 감소하고 Ca수준이 증가할수록 감소하는 경향을 보였다. 계란의 비중과 난각강도 및 난각후도 등 난각질은 모두 대조구에 비해 시험구(71-73)들이 유의적으로 향상되었고(P<0.05),오후사료의 Ca수준이 증가할수록 향상되는 경향을 보였다. 실험 2에서 헨데이 산란율은 처리간에 유의적인 차이가 없었으나, 평균난중과 1일 1수당 사료섭취량은 대조구에 비해 오전사료와 오후사료의 별도급여구(T1)와 혼합급여구(T2)가 감소하는 경향을 보였다(P<0.05). 1일 1수당 ME, CP섭취량 및 사료비는 모두 대조구에 비해 T1과 T2구가 유의적으로 감소하였고(P<0.05), T1과 T2간에는 유의차가 없었다. 산란 개당 ME와 CP요구량 및 사료비는 모두 대조구에 비해 T1과 T2구가 유의적으로 감소하였으나(P<0.05), 산란kg 당 사료, ME, CP요구량 및 사료비는 모두 처리간에 유의적인 차이가 없었다. 계란의 비중과 난각후도는 대조구에 비해 T1과 T2구가 유의적으로 향상되었고(P<0.05), 난각강도는 처리간에 유의적인 차이가 없었으나, T1과 T2구가 대조구보다 향상되는 경향을 보였다. 본 시험 결과 오전용 사료는 관행적인 산란계 배합사료에서 Ca공급제를 제외한 것을 급여하고, 오후용 사료는 Ca공급제를 3배 첨가한 T2처리로 15:00~16:00시에 교체급여를 하면 사료섭취량 감소와 사료비 절감면에서 바람직할 것으로 사료되며, 고에너지-고단백질-저Ca의 분말사료와 저에너지-저단백질-고Ca의 펠렛사료를 혼합급여하면 산란계의 사료섭취 량과 사료비를 절감할 수 있었으며, 오전사료와 오후사료 별도급여의 번거로움을 피할 수 있는 사양체계로 기대가 되나 보다 더 많은 연구가 필요하다.

• Journal of Nutrition and Health
• /
• 제15권2호
• /
• pp.119-128
• /
• 1982

The effect of dietary protein on growth and lipid levels of plasma and liver was studied in weanling male rats fed diets differing protein sources and amino acid balance. Rats were devided into 9 experimental diets which were grouped into 3 categories ; 1) Simple protein category includes gluten-, soy protein isolate-, and casein-containing diet groups, 2) Supplemented category includes casein supplemented with methionine, soy protein isolate supplemented with methionine, and gluten supplemented with lysine and methionine, 3) Mixed protein category includes diet groups containing gluten (2/3), casein (1/3), soy protein isolate (2/3) and casein (1/3), and casein (1/3), soy protein isolate (1/3) and gluten (1/3). The experimental diets composed of 15% protein, 65.8% carbohydrate, 10% fat and 1% cholesterol. The body wt. gain and P.E.R. were greater in rats of supplemented and mixed protein groups than simple protein groups. No statistical differences were found in plasma cholesterol among gluten, soy protein isolate and casein groups. Consumption of diets supplemented with limiting amino acid to gluten or soy protein isolate reduced the plasma cholesterol level by 23.2% and 34.2% respectively. However there was no difference between casein and the supplemented casein groups. The mixed protein groups shows relatively high plasma cholesterol concentration and low liver cholesterol levels. On the other hand gluten group showed low plasma cholesterol and high liver cholesterol levels, which means body cholesterol pool may not have been changed by the dietary protein. Feeding soy protein meal and the supplemented soy protein isolate resulted in lower plasma cholesterol, plasma triglycerides, liver cholesterol and liver triglycerides levels. This hypolipidemic effect is considered to see unique to soy protein isolate. Rats in gluten and the supplemented gluten groups showed lower plasma protein levels and a tendency of fatty liver.

• Asian-Australasian Journal of Animal Sciences
• /
• 제28권9호
• /
• pp.1317-1326
• /
• 2015

This study investigated the metabolizable energy (ME) intake, net energy of production (NEp), heat production (HP), efficiencies of ME use for energy, lipid and protein retention as well as the performance of broiler chickens fed diets based on cassava chips or pellets with or without supplementation with an enzyme product containing xylanase, amylase, protease and phytase. The two products, cassava chips and pellets, were analysed for nutrient composition prior to feed formulation. The cassava chips and pellets contained 2.2% and 2.1% crude protein; 1.2% and 1.5% crude fat; and 75.1% and 67.8% starch, respectively. Lysine and methionine were 0.077%, 0.075%, and 0.017%, 0.020% protein material, respectively, while calculated ME was 12.6 and 11.7 MJ/kg, respectively. Feed intake to day 21 was lower (p<0.01) on the diet containing cassava chips compared to diets with cassava pellets. Enzyme supplementation increased (p<0.01) feed intake on all diets. Live weight at day 21 was significantly (p<0.01) reduced on the diet based on cassava chips compared to pellets, but an improvement (p<0.01) was noticed with the enzyme supplementation. Metabolizable energy intake was reduced (p<0.01) by both cassava chips and pellets, but was increased (p<0.01) on all diets by enzyme supplementation. The NEp was higher (p<0.01) in the maize-based diets than the diets containing cassava. Enzyme supplementation improved (p<0.01) NEp in all the diets. Heat production was highest (p<0.01) on diets containing cassava pellets than on cassava chips. It is possible to use cassava pellets in diets for broiler chickens at a level close to 50% of the diet to reduce cost of production, and the nutritive value of such diets can be improved through supplementation of enzyme products containing carbohydrases, protease, and phytase.

• Journal of Microbiology and Biotechnology
• /
• 제31권2호
• /
• pp.207-216
• /
• 2021

Supplement of high-protein food plays an important role in improving the symptoms of malnutrition and the immune capacity of the body, but the association of high-protein diet and gut microbiota remained unaddressed. Here, we systematically analyzed the internal organs and gut microbiota in C57(WT) or PD-1H-depleted (KO) mice (T cells were activated) fed with pupae or feed for six weeks. We observed that the body weight gain in the mice fed with pupae increased less significantly than that of the feed group, while the villi and small intestine lengths in the pupa group were reduced compared with that of mice given feed. However, the average body weight of the KO mice increased compared with that of the WT mice fed with pupae or feed. Pupae increased the concentration of blood glucose in WT, but not in KO mice. Moreover, in the feed group, there was no difference in the weight of the internal organs between the WT and KO mice, but in the pupae-fed group, liver weight was decreased and spleen weight was increased compared with that of KO mice. The amounts/plural/amounts of Melainabacteria, Chloroflexi, and Armatimonadetes were specifically upregulated by pupae, and this upregulation was weakened or eliminated by PD-1H depletion. Some bacteria with high abundance in the feed-fed KO mice, such as Deferribacteres, Melainabacteria, Acidobacteria, Bacteroidetes, Spirochaetes and Verrucomicrobia, were decreased in pupae-fed KO mice, and Proteobacteria and Deinococcus were specifically enriched in pupae-fed KO mice. Bacteroidetes, Firmicutes and Akkermansia were associated with weight loss in the pupae-fed group while Lachnospiraceae and Anaerobiospirillum were related glucose metabolism and energy consumption. Based on high-throughput sequencing, we discovered that some gut bacteria specifically regulated the metabolism of a high-protein diet, and PD-1H deficiency improved life quality and sustained blood glucose. Moreover, PD-1H responses to high-protein diet through modulating the type and quantity of gut bacteria. These findings provide evidence about the association among gut microbiota, T cell activation (for PD-1H depletion) and high-protein diet metabolism, have important theoretical significance for nutrition and health research.

• Nutrition Research and Practice
• /
• 제17권6호
• /
• pp.1099-1112
• /
• 2023

BACKGROUND/OBJECTIVES: Dyslipidemia causes metabolic disorders such as atherosclerosis and fatty liver syndrome due to abnormally high blood lipids. Purple perilla frutescens extract (PPE) possesses various bioactive compounds such as α-asarone, chlorogenic acid and rosmarinic acid. This study examined whether PPE and α-asarone improved dyslipidemia-associated inflammation and inhibited atheroma formation in apolipoprotein E (apoE)-deficient mice, an experimental animal model of atherosclerosis. MATERIALS/METHODS: ApoE-deficient mice were fed on high cholesterol-diet (Paigen's diet) and orally administrated with 10-20 mg/kg PPE and α-asarone for 10 wk. RESULTS: The Paigen's diet reduced body weight gain in apoE-deficient mice, which was not restored by PPE or α-asarone. PPE or α-asarone improved the plasma lipid profiles in Paigen's diet-fed apoE-deficient mice, and despite a small increase in high-density lipoprotein cholesterol (HDL-C), low-density lipoprotein (LDL)-cholesterol, and very LDL were significantly reduced. Paigen's diet-induced systemic inflammation was reduced in PPE or α-asarone-treated apoE-deficient mice. Supplying PPE or α-asarone to mice lacking apoE suppressed aorta atherogenesis induced by atherogenic diet. PPE or α-asarone diminished aorta accumulation of CD68- and/or F4/80-positive macrophages induced by atherogenic diet in apoE-deficient mice. Treatment of apoE-deficient mice with PPE and α-asarone resulted in a significant decrease in plasma cholesteryl ester transfer protein level and an increase in lecithin:cholesterol acyltransferase reduced by supply of Paigen's diet. Supplementation of PPE and α-asarone enhanced the transcription of hepatic apoA1 and SR-B1 reduced by Paigen's diet in apoE-deficient mice. CONCLUSIONS: α-Asarone in PPE inhibited inflammation-associated atheroma formation and promoted hepatic HDL-C trafficking in dyslipidemic mice.

• BMB Reports
• /
• 제56권4호
• /
• pp.246-251
• /
• 2023

Obesity increases the risk of mortality and morbidity because it results in hypertension, heart disease, and type 2 diabetes. Therefore, there is an urgent need for pharmacotherapeutic drugs to treat obesity. We performed a screening assay using natural products with anti-adipogenic properties in 3T3-L1 cells and determined that tschimganidine, a terpenoid from the Umbelliferae family, inhibited adipogenesis. To evaluate the anti-obesity effects of tschimganidine in vivo. Mice were fed either a normal chow diet (NFD) or a high-fat chow diet (HFD) with or without tschimganidine for 12 weeks. Treatment with tschimganidine decreased lipid accumulation and adipogenesis, accompanied by reduced expression of adipogenesis and lipid accumulation-related factors. Tschimganidine significantly increased the phosphorylation of AMP-activated protein kinase (AMPK) and decreased that of AKT. Depletion of AMPK relieved the reduction in lipid accumulation resulting from tschimganidine treatment. Moreover, tschimganidine administration drastically reduced the weight and size of both gonadal white adipose tissue (WAT) and blood glucose levels in high-fat diet-induced obese mice. We suggest that tschimganidine is a potent anti-obesity agent, which impedes adipogenesis and improves glucose homeostasis. Tschimganidine can then be evaluated for clinical application as a therapeutic agent.

• Asian-Australasian Journal of Animal Sciences
• /
• 제25권5호
• /
• pp.659-664
• /
• 2012

The present experiment aimed to evaluate the effect of HMBi on the production performance and metabolism in dairy cows. Thirty multiparous Holstein dairy cows under similar conditions were randomly assigned to three dietary treatments; i) Control, a basal diet; ii) T1, a basal diet plus HMBi (0 g prepartum and 18 g postpartum); and iii) T2, a basal diet plus HMBi (10 g prepartum and 18 g postpartum). Treatments were initiated 21 d before expected calving and continued through 91 d postpartum. HMBi was top-dressed onto the total mixed ration of each cow. Treatments did not affect dry matter intake, plasma urea nitrogen, peak milk yield, days to peak milk yield, nonesterified fatty acid, glutamate pyruvate transaminase, glutamic oxalaetic transaminase, milk fat content, milk protein content, milk lactose content, and milk solid non-fat content. The milk composition yields were increased by the HMBi-supplemented treatment. The T1 and T2 treatments increased the yields of 4% fat-corrected milk yield, milk fat, milk protein, and milk lactose compared with the control. Although there was no difference in the milk composition of the control and T2-treated cows, the T2-treated cows exhibited higher milk fat yield (increased by 74 g/d), lower milk urea nitrogen (reduced by 3.41%), and plasma ${\beta}$-hydroxy butyrate than the control cows. The results indicate that HMBi supplementation to diet has beneficial effects, and that there is no difference between supplementation at prepartum and starting only at parturition.

• 한국양식학회지
• /
• 제5권1호
• /
• pp.9-17
• /
• 1992

참돔 치어에 있어서의 식물성단백질원의 이용성의 검토와 유효이용을 꾀하기 위하여, 대두박 및 콘글루텐 밀을 배합한 여러 종류의 실험사료를 제작하여 성장, 사료효율 및 어체성분에 미치는 영향을 조사하였다. 그 결과 사료중의 조단백질 및 조지폐함량이 각각 $47{\%}\;,20{\%}$ 구에서 뛰어난 성장 및 사료효율을 나타내었으며, 어분의 $20{\%}$를 대두박으로 대체하여도 성장 및 사료효율에는 아무튼 간제가 없는 것으로 판단되었다. 그리고, 원료대두박의 Ex 처리유무 및 사료의 제조법의 차이에 의한 영양가개선을 인정할 수 없었다.

• Asian-Australasian Journal of Animal Sciences
• /
• 제21권5호
• /
• pp.663-670
• /
• 2008

The effect of supplementing the diet of grazing dairy cows with fish oil (FO) and linseed oil (LSO) on milk conjugated linoleic acid (CLA) was investigated. Sixteen Holstein cows (17019 DIM) were assigned into two groups and fed a grain supplement (8.0 kg/d; DM basis) containing 800 g of saturated animal fat (CONT) or 200 g FO and 600 g LSO (FOLSO). All cows grazed together on Sudan grass pasture ad libitum and were fed the treatment diets for 3 wks. Cows were milked twice a day and milk samples were collected during the last three days of the trial. Milk production (24.89 and 22.45 kg/d), milk protein percentage (2.76 and 2.82) and milk protein yield (0.68 and 0.64 kg/d) for the CONT and FOLSO diets, respectively, were not affected (p>0.05) by treatment diets. Milk fat percentage (3.90 and 2.86) and milk fat yield (0.97 and 0.64 kg/d) were lower (p<0.05) with the FOLSO diet compared with the CONT diet. The concentration and yield of milk cis-9 trans-11 CLA were higher (p<0.05) with the FOLSO diet (2.56% of total FA and 16.44 g/d, respectively) than the CONT diet (0.66% of total FA and 6.44 g/d, respectively). The concentrations of milk trans C18:1 and vaccenic acid (VA) were higher (p<0.05) with the FOLSO diet (13.53 and 7.48% of total FA, respectively) than the CONT diet (3.69 and 2.27% of total FA, respectively). In conclusion, supplementing the diet of grazing cows with FO and LSO increased milk cis-9 trans-11 CLA content but reduced milk fat content and yield.

• Nutrition Research and Practice
• /
• 제12권4호
• /
• pp.298-306
• /
• 2018

BACKGROUND/OBJECTIVES: Obesity is a global health problem of significant importance which increases mortality. In place of anti-obesity drugs, natural products are being developed as alternative therapeutic materials. In this study, we investigated the effect of Brassica juncea L. leaf extract (BLE) on fat deposition and lipid profiles in high-fat, high-cholesterol diet (HFC)-induced obese rats. MATERIALS/METHODS: Male Sprague-Dawley rats were divided into four groups (n = 8 per group) according to diet: normal diet group (ND), high-fat/high-cholesterol diet group (HFC), HFC with 3% BLE diet group (HFC-A1), and HFC with 5% BLE diet group (HFC-A2). Each group was fed for 6 weeks. Rat body and adipose tissue weights, serum biochemical parameters, and tissue lipid contents were determined. The expression levels of mRNA and proteins involved in lipid and cholesterol metabolism were determined by reverse transcription polymerase chain reaction and western blot analysis, respectively. RESULTS: The HFC-A2 group showed significantly lower body weight gain and food efficiency ratio than the HFC group. BLE supplementation caused mesenteric, epididymal, and total adipose tissue weights to decrease. The serum levels of triglyceride, total cholesterol, and low-density lipoprotein cholesterol were significantly reduced, and high-density lipoprotein cholesterol was significantly increased in rats fed BLE. These results were related to lower glucose-6-phosphate dehydrogenase, acetyl-coA carboxylase, and fatty acid synthase mRNA expression, and to higher expression of the cholesterol $7{\alpha}$-hydroxylase and low density lipoprotein-receptor, as well as increased protein levels of peroxisome proliferator-activated receptor ${\alpha}$. Histological analysis of the liver revealed decreased lipid droplets in HFC rats treated with BLE. CONCLUSIONS: Supplementation of HFC with 3% or 5% BLE inhibited body fat accumulation, improved lipid profiles, and modulated lipogenesis- and cholesterol metabolism-related gene and protein expression.